We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
-13.75%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$713M
AUM Growth
-$97.1M
Cap. Flow
+$15.7M
Cap. Flow %
2.2%
Top 10 Hldgs %
21.39%
Holding
340
New
71
Increased
82
Reduced
98
Closed
62

Sector Composition

Rank Sector Weight
1 Financials 19.4%
2 Technology 15.43%
3 Healthcare 14.56%
4 Consumer Discretionary 14.04%
5 Industrials 10.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLXP
251
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$241K 0.03%
2,153
-25
-1% -$2.88K
BLK icon
252
Blackrock
BLK
$175B
$239K 0.03%
803
RYAM icon
253
Rayonier Advanced Materials
RYAM
$593M
$237K 0.03%
38,691
+15,487
+67% +$157K
CWST icon
254
Casella Waste Systems
CWST
$5.72B
$236K 0.03%
40,719
-700
-2% -$4.28K
ATW
255
DELISTED
Atwood Oceanics
ATW
$225K 0.03%
15,192
PFE icon
256
Pfizer
PFE
$154B
$221K 0.03%
7,404
ETD icon
257
Ethan Allen Interiors
ETD
$598M
$216K 0.03%
8,196
-11,487
-58% -$337K
HZN
258
DELISTED
Horizon Global Corporation
HZN
$207K 0.03%
+23,461
New +$262K
GD icon
259
General Dynamics
GD
$107B
$202K 0.03%
1,467
LFCR icon
260
Lifecore Biomedical
LFCR
$176M
$192K 0.03%
+16,446
New +$218K
IRG
261
DELISTED
Ignite Restaurant Group, Inc.
IRG
$188K 0.03%
38,811
-20,285
-34% -$99.5K
MCHX icon
262
Marchex
MCHX
$79.3M
$185K 0.03%
45,785
-750
-2% -$3.19K
EPM icon
263
Evolution Petroleum
EPM
$134M
$174K 0.02%
+31,420
New +$174K
GNMK
264
DELISTED
GenMark Diagnostics, Inc
GNMK
$170K 0.02%
+21,552
New +$199K
YELL
265
DELISTED
Yellow Corporation Common Stock
YELL
$170K 0.02%
+12,838
New +$201K
ACHV icon
266
Achieve Life Sciences
ACHV
$685M
$156K 0.02%
32
VMEM
267
DELISTED
VIOLIN MEMORY, INC.
VMEM
$150K 0.02%
27,157
-21,955
-45% -$175K
EIGI
268
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$143K 0.02%
+10,738
New +$185K
OSUR icon
269
OraSure Technologies
OSUR
$275M
$134K 0.02%
30,075
-400
-1% -$2.09K
KERX
270
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$134K 0.02%
38,125
ARGS
271
DELISTED
Argos Therapeutics, Inc.
ARGS
$130K 0.02%
1,351
-15
-1% -$1.78K
NNVC icon
272
NanoViricides
NNVC
$35.7M
$127K 0.02%
5,324
-300
-5% -$7.94K
REXX
273
DELISTED
Rex Energy Corporation
REXX
$123K 0.02%
5,923
-60
-1% -$1.73K
ARIA
274
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$114K 0.02%
+19,554
New +$151K
HUN icon
275
Huntsman Corp
HUN
$1.82B
$109K 0.02%
11,205

Similar funds

Stoneridge Investment Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Stoneridge Investment Partners held 340 positions worth $713M, down 12% from $810M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Stoneridge Investment Partners's Q3 2015 filing shows 71 new, 82 increased, 98 reduced and 62 closed positions. Its largest new stake was Viatris: 408,857 shares worth $16.5M. The largest sale was Johnson & Johnson, an estimated $20.9M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Stoneridge Investment Partners's largest Q3 2015 buy was Viatris: 408,857 shares worth $16.5M.
  • Stoneridge Investment Partners added most to Kohl's in Q3 2015, an estimated $17.8M increase.
  • Stoneridge Investment Partners's biggest Q3 2015 reduction was Johnson & Johnson, cutting an estimated $20.9M.
  • Stoneridge Investment Partners fully exited Teva Pharmaceuticals in Q3 2015, selling an estimated $8.7M.
  • Stoneridge Investment Partners's ten largest holdings make up 21% of its $713M portfolio in Q3 2015.
  • Stoneridge Investment Partners opened 71 new positions and closed 62 in Q3 2015.
  • Stoneridge Investment Partners's portfolio value fell 12% quarter-over-quarter to $713M.

Based on Stoneridge Investment Partners's 13F filing for Q3 2015, filed 26 Oct 2015.